Zenas BioPharma, Inc.
ZBIO
$16.93
$0.613.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 273.28M | 312.38M | 350.77M | 386.80M | 183.93M |
| Total Receivables | 1.30M | 1.70M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.02M | 3.73M | 3.07M | 6.98M | 3.47M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 2.09M | -- | 1.20M |
| Total Current Assets | 278.60M | 317.81M | 355.92M | 393.78M | 188.60M |
|
|
|||||
| Total Current Assets | 278.60M | 317.81M | 355.92M | 393.78M | 188.60M |
| Net Property, Plant & Equipment | 1.07M | 1.28M | 1.19M | 545.00K | 706.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.80M | 12.85M | 12.86M | 9.11M | 10.65M |
| Total Assets | 293.09M | 333.77M | 369.97M | 403.43M | 199.95M |
|
|
|||||
| Total Accounts Payable | 7.93M | 20.02M | 17.14M | 15.08M | 8.36M |
| Total Accrued Expenses | 44.52M | 28.20M | 39.16M | 28.53M | 29.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 793.00K | 908.00K | 785.00K | 384.00K | 494.00K |
| Total Finance Division Other Current Liabilities | -- | 5.00K | 211.00K | -- | 530.00K |
| Total Other Current Liabilities | -- | 5.00K | 211.00K | -- | 530.00K |
| Total Current Liabilities | 53.24M | 49.13M | 57.29M | 44.00M | 39.11M |
|
|
|||||
| Total Current Liabilities | 53.24M | 49.13M | 57.29M | 44.00M | 39.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 215.00K | 317.00K | 218.00K | -- | 14.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 53.46M | 49.45M | 57.51M | 44.00M | 39.12M |
|
|
|||||
| Common Stock & APIC | 712.91M | 705.14M | 699.66M | 694.17M | 7.29M |
| Retained Earnings | -473.19M | -420.96M | -387.39M | -334.79M | -296.18M |
| Treasury Stock & Other | -94.00K | 141.00K | 194.00K | 54.00K | 104.00K |
| Total Common Equity | 239.63M | 284.32M | 312.46M | 359.44M | -288.78M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 449.61M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 449.61M |
|
|
|||||
| Total Common Equity | 239.63M | 284.32M | 312.46M | 359.44M | -288.78M |
| Total Preferred Equity | -- | -- | -- | -- | 449.61M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 239.63M | 284.32M | 312.46M | 359.44M | 160.83M |
|
|
|||||